| scholarly article | Q13442814 |
| P50 | author | Marco Matucci-Cerinic | Q19859583 |
| P2093 | author name string | Yannick Allanore | |
| Dinesh Khanna | |||
| Oliver Distler | |||
| Christophe Meune | |||
| Robert Lafyatis | |||
| Alessandra Vacca | |||
| Shervin Assassi | |||
| Mandana Nikpour | |||
| Susanna Proudman | |||
| Jessica Gordon | |||
| Tatiana S Rodriguez-Reyna | |||
| Lorinda Chung | |||
| Scleroderma Clinical Trial Consortium Cardiac Subcommittee | |||
| P2860 | cites work | Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies | Q26864958 |
| The effect of metoprolol alone and combined metoprolol-felodipin on the digital microcirculation of patients with primary Raynaud's syndrome | Q33880452 | ||
| Clinical and genetic factors predictive of mortality in early systemic sclerosis | Q33903786 | ||
| Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study | Q34127570 | ||
| Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands | Q34142052 | ||
| Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis | Q35555996 | ||
| Primary myocardial involvement in systemic sclerosis | Q36596341 | ||
| Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases | Q36596360 | ||
| Outcome measures for heart involvement in systemic sclerosis | Q37265857 | ||
| Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients | Q37404896 | ||
| Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management | Q37959313 | ||
| The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies | Q37973712 | ||
| The electrocardiogram in systemic sclerosis (scleroderma). Study of 102 consecutive cases with functional correlations and review of the literature | Q39614635 | ||
| Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis | Q39877290 | ||
| High prevalence of right ventricular systolic dysfunction in early systemic sclerosis. | Q45093377 | ||
| Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias. | Q50669020 | ||
| Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database | Q56974596 | ||
| The cardiac conduction system in progressive systemic sclerosis. Clinical and pathologic features of 35 patients | Q67804270 | ||
| Prognostic importance of cardiac arrhythmias in systemic sclerosis | Q68385979 | ||
| Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis | Q69634697 | ||
| Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association | Q70523026 | ||
| Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma | Q71252764 | ||
| The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis | Q71427003 | ||
| Electrophysiologic abnormalities of cardiac function in progressive systemic sclerosis | Q71535536 | ||
| Relationships between electrocardiographic and echocardiographic findings in systemic sclerosis (scleroderma) | Q73024605 | ||
| Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study | Q81517420 | ||
| Heart rate turbulence assessment in systemic sclerosis: the role for the detection of cardiac autonomic nervous system dysfunction | Q82230267 | ||
| Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis | Q84245189 | ||
| Electrocardiographic evaluation in patients with systemic scleroderma and without clinically evident heart disease | Q84247735 | ||
| Noninvasive evaluation of cardiac dysrhythmias, and their relationship with multisystemic symptoms, in progressive systemic sclerosis patients | Q93644161 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 1172-1177 | |
| P577 | publication date | 2013-11-15 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | Cardiac arrhythmias and conduction defects in systemic sclerosis | |
| P478 | volume | 53 |
| Q89909178 | A patient-centered approach to the burden of symptoms in patients with scleroderma treated with Bosentan: A prospective single-center observational study |
| Q36375900 | A prediction model for progressive disease in systemic sclerosis |
| Q64980849 | Bundle Branch Blocks and Fragmented QRS Complex in Iranian Patients with Systemic Sclerosis. |
| Q92852059 | Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study |
| Q92675244 | Electrocardiographic markers for the prediction of ventricular arrhythmias in patients with systemic sclerosis |
| Q49072027 | European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes. |
| Q51835838 | Immune-Mediated Heart Disease. |
| Q38733776 | Lung Transplantation in Patients With Systemic Sclerosis |
| Q90966606 | Major lung complications of systemic sclerosis |
| Q35961706 | Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial |
| Q47835792 | Points to consider when doing a trial primarily involving the heart |
| Q35996165 | Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome |
| Q57801056 | Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China |
| Q90624952 | Restrictive cardiomyopathy in a patient with systemic sclerosis and Fabry disease: a case-based review |
| Q87842869 | Systemic sclerosis |
| Q90243697 | Systemic sclerosis - multidisciplinary disease: clinical features and treatment |
| Q38807743 | The heart and pulmonary arterial hypertension in systemic sclerosis |
| Q36709262 | Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis |
Search more.